A Unifying Mutation in Chronic Myeloproliferative Disorders
- 28 April 2005
- journal article
- editorial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 352 (17) , 1744-1746
- https://doi.org/10.1056/nejmp058083
Abstract
In 1892, Louis Vaquez of Paris described a patient with cyanotic polycythemia; the autopsy disclosed massive enlargement of the spleen and liver. In 1903, William Osler, then at Johns Hopkins Hospital, reported on four patients with polycythemia, two of whom had splenomegaly. He gave credit to Vaquez for the earlier description, and the disorder was later named Osler–Vaquez disease, though today it is usually referred to as polycythemia vera.In 1951, William Dameshek drew attention to the relationships among polycythemia vera, idiopathic myelofibrosis, and essential thrombocythemia and proposed that these diseases, as well as chronic myeloid leukemia and erythroleukemia, should . . .Keywords
This publication has 3 references indexed in Scilit:
- A Gain-of-Function Mutation ofJAK2in Myeloproliferative DisordersNew England Journal of Medicine, 2005
- Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disordersThe Lancet, 2005
- The Janus kinases (Jaks)Genome Biology, 2004